(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea

C163H223N45O26 — CID 162280275

IUPAC(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea
SMILESCC(C)(C)c1ccc(NC(=O)NCCCN(CC2CC2)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1.CC(C)(C)c1ccc(NC(=O)NCCCN(Cc2ccccc2)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1.CC(C)[C@@H](CCN(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)NC(=O)Nc1ccc(C(C)(C)C)cc1.CN(CCCCC(=O)Cc1ccc2c(c1)OCO2)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.CN(CCCCc1cc2cc(C(C)(C)C)ccc2[nH]1)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.CN(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)CCNC(=O)Nc1ccc(C(C)(C)C)cc1
InChIInChI=1S/C31H40N8O4.C28H40N8O4.C28H42N8O4.C27H37N7O3.C25H34N8O5.C24H30N6O6/c1-31(2,3)21-10-12-22(13-11-21)37-30(42)33-14-7-15-38(16-20-8-5-4-6-9-20)17-23-25(40)26(41)29(43-23)39-19-36-24-27(32)34-18-35-28(24)39;1-28(2,3)18-7-9-19(10-8-18)34-27(39)30-11-4-12-35(13-17-5-6-17)14-20-22(37)23(38)26(40-20)36-16-33-21-24(29)31-15-32-25(21)36;1-16(2)19(34-27(39)33-18-9-7-17(8-10-18)28(3,4)5)11-12-35(6)13-20-22(37)23(38)26(40-20)36-15-32-21-24(29)30-14-31-25(21)36;1-27(2,3)17-8-9-19-16(11-17)12-18(32-19)7-5-6-10-33(4)13-20-22(35)23(36)26(37-20)34-15-31-21-24(28)29-14-30-25(21)34;1-25(2,3)14-5-7-15(8-6-14)31-24(37)27-10-9-17(34)32(4)11-16-19(35)20(36)23(38-16)33-13-30-18-21(26)28-12-29-22(18)33;1-29(7-3-2-4-15(31)8-14-5-6-16-17(9-14)35-13-34-16)10-18-20(32)21(33)24(36-18)30-12-28-19-22(25)26-11-27-23(19)30/h4-6,8-13,18-19,23,25-26,29,40-41H,7,14-17H2,1-3H3,(H2,32,34,35)(H2,33,37,42);7-10,15-17,20,22-23,26,37-38H,4-6,11-14H2,1-3H3,(H2,29,31,32)(H2,30,34,39);7-10,14-16,19-20,22-23,26,37-38H,11-13H2,1-6H3,(H2,29,30,31)(H2,33,34,39);8-9,11-12,14-15,20,22-23,26,32,35-36H,5-7,10,13H2,1-4H3,(H2,28,29,30);5-8,12-13,16,19-20,23,35-36H,9-11H2,1-4H3,(H2,26,28,29)(H2,27,31,37);5-6,9,11-12,18,20-21,24,32-33H,2-4,7-8,10,13H2,1H3,(H2,25,26,27)/t23-,25-,26-,29-;20-,22-,23-,26-;19-,20-,22-,23-,26-;20-,22-,23-,26-;16-,19-,20-,23-;18-,20-,21-,24-/m111111/s1
InChIKeyXKPCCPYZSOENSI-LOMYJWOZSA-N
MW3228.87 g/mol
LogP12.21
Rot. Bonds54

About (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea (PubChem CID 162280275) has the molecular formula C163H223N45O26 and a molecular weight of 3228.87 g/mol. Its IUPAC name is (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea.

Molecular Properties

Compound Name(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea
PubChem CID162280275
Molecular FormulaC163H223N45O26
Molecular Weight3228.87 g/mol
Exact Mass3226.75
IUPAC Name(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea
SMILESCC(C)(C)c1ccc(NC(=O)NCCCN(CC2CC2)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1.CC(C)(C)c1ccc(NC(=O)NCCCN(Cc2ccccc2)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1.CC(C)[C@@H](CCN(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)NC(=O)Nc1ccc(C(C)(C)C)cc1.CN(CCCCC(=O)Cc1ccc2c(c1)OCO2)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.CN(CCCCc1cc2cc(C(C)(C)C)ccc2[nH]1)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.CN(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)CCNC(=O)Nc1ccc(C(C)(C)C)cc1
InChIInChI=1S/C31H40N8O4.C28H40N8O4.C28H42N8O4.C27H37N7O3.C25H34N8O5.C24H30N6O6/c1-31(2,3)21-10-12-22(13-11-21)37-30(42)33-14-7-15-38(16-20-8-5-4-6-9-20)17-23-25(40)26(41)29(43-23)39-19-36-24-27(32)34-18-35-28(24)39;1-28(2,3)18-7-9-19(10-8-18)34-27(39)30-11-4-12-35(13-17-5-6-17)14-20-22(37)23(38)26(40-20)36-16-33-21-24(29)31-15-32-25(21)36;1-16(2)19(34-27(39)33-18-9-7-17(8-10-18)28(3,4)5)11-12-35(6)13-20-22(37)23(38)26(40-20)36-15-32-21-24(29)30-14-31-25(21)36;1-27(2,3)17-8-9-19-16(11-17)12-18(32-19)7-5-6-10-33(4)13-20-22(35)23(36)26(37-20)34-15-31-21-24(28)29-14-30-25(21)34;1-25(2,3)14-5-7-15(8-6-14)31-24(37)27-10-9-17(34)32(4)11-16-19(35)20(36)23(38-16)33-13-30-18-21(26)28-12-29-22(18)33;1-29(7-3-2-4-15(31)8-14-5-6-16-17(9-14)35-13-34-16)10-18-20(32)21(33)24(36-18)30-12-28-19-22(25)26-11-27-23(19)30/h4-6,8-13,18-19,23,25-26,29,40-41H,7,14-17H2,1-3H3,(H2,32,34,35)(H2,33,37,42);7-10,15-17,20,22-23,26,37-38H,4-6,11-14H2,1-3H3,(H2,29,31,32)(H2,30,34,39);7-10,14-16,19-20,22-23,26,37-38H,11-13H2,1-6H3,(H2,29,30,31)(H2,33,34,39);8-9,11-12,14-15,20,22-23,26,32,35-36H,5-7,10,13H2,1-4H3,(H2,28,29,30);5-8,12-13,16,19-20,23,35-36H,9-11H2,1-4H3,(H2,26,28,29)(H2,27,31,37);5-6,9,11-12,18,20-21,24,32-33H,2-4,7-8,10,13H2,1H3,(H2,25,26,27)/t23-,25-,26-,29-;20-,22-,23-,26-;19-,20-,22-,23-,26-;20-,22-,23-,26-;16-,19-,20-,23-;18-,20-,21-,24-/m111111/s1
InChIKeyXKPCCPYZSOENSI-LOMYJWOZSA-N
XLogP12.21
TPSA968.21 Ų
H-Bond Donors27
H-Bond Acceptors61
Rotatable Bonds54
Heavy Atoms234
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003228.87
LogP ≤ 512.21
H-Bond Donors ≤ 527
H-Bond Acceptors ≤ 1061

Analyze (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea?
The IUPAC name of (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea (CID 162280275) is (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea.
What is the SMILES notation for (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea?
The canonical SMILES for (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea is CC(C)(C)c1ccc(NC(=O)NCCCN(CC2CC2)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1.CC(C)(C)c1ccc(NC(=O)NCCCN(Cc2ccccc2)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1.CC(C)[C@@H](CCN(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)NC(=O)Nc1ccc(C(C)(C)C)cc1.CN(CCCCC(=O)Cc1ccc2c(c1)OCO2)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.CN(CCCCc1cc2cc(C(C)(C)C)ccc2[nH]1)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.CN(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)CCNC(=O)Nc1ccc(C(C)(C)C)cc1.
What is the InChIKey of (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea?
The InChIKey is XKPCCPYZSOENSI-LOMYJWOZSA-N. The full InChI is InChI=1S/C31H40N8O4.C28H40N8O4.C28H42N8O4.C27H37N7O3.C25H34N8O5.C24H30N6O6/c1-31(2,3)21-10-12-22(13-11-21)37-30(42)33-14-7-15-38(16-20-8-5-4-6-9-20)17-23-25(40)26(41)29(43-23)39-19-36-24-27(32)34-18-35-28(24)39;1-28(2,3)18-7-9-19(10-8-18)34-27(39)30-11-4-12-35(13-17-5-6-17)14-20-22(37)23(38)26(40-20)36-16-33-21-24(29)31-15-32-25(21)36;1-16(2)19(34-27(39)33-18-9-7-17(8-10-18)28(3,4)5)11-12-35(6)13-20-22(37)23(38)26(40-20)36-15-32-21-24(29)30-14-31-25(21)36;1-27(2,3)17-8-9-19-16(11-17)12-18(32-19)7-5-6-10-33(4)13-20-22(35)23(36)26(37-20)34-15-31-21-24(28)29-14-30-25(21)34;1-25(2,3)14-5-7-15(8-6-14)31-24(37)27-10-9-17(34)32(4)11-16-19(35)20(36)23(38-16)33-13-30-18-21(26)28-12-29-22(18)33;1-29(7-3-2-4-15(31)8-14-5-6-16-17(9-14)35-13-34-16)10-18-20(32)21(33)24(36-18)30-12-28-19-22(25)26-11-27-23(19)30/h4-6,8-13,18-19,23,25-26,29,40-41H,7,14-17H2,1-3H3,(H2,32,34,35)(H2,33,37,42);7-10,15-17,20,22-23,26,37-38H,4-6,11-14H2,1-3H3,(H2,29,31,32)(H2,30,34,39);7-10,14-16,19-20,22-23,26,37-38H,11-13H2,1-6H3,(H2,29,30,31)(H2,33,34,39);8-9,11-12,14-15,20,22-23,26,32,35-36H,5-7,10,13H2,1-4H3,(H2,28,29,30);5-8,12-13,16,19-20,23,35-36H,9-11H2,1-4H3,(H2,26,28,29)(H2,27,31,37);5-6,9,11-12,18,20-21,24,32-33H,2-4,7-8,10,13H2,1H3,(H2,25,26,27)/t23-,25-,26-,29-;20-,22-,23-,26-;19-,20-,22-,23-,26-;20-,22-,23-,26-;16-,19-,20-,23-;18-,20-,21-,24-/m111111/s1.
What are the key properties of (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea?
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea has a molecular weight of 3228.87 g/mol, XLogP of 12.21, 54 rotatable bonds, 27 hydrogen bond donors, and 61 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[4-(5-tert-butyl-1H-indol-2-yl)butyl-methylamino]methyl]oxolane-3,4-diol;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-benzylamino]propyl]-3-(4-tert-butylphenyl)urea;N-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-[(4-tert-butylphenyl)carbamoylamino]-N-methylpropanamide;1-[3-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-(cyclopropylmethyl)amino]propyl]-3-(4-tert-butylphenyl)urea;6-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-1-(1,3-benzodioxol-5-yl)hexan-2-one;1-[(3R)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]-4-methylpentan-3-yl]-3-(4-tert-butylphenyl)urea is sourced from PubChem (CID 162280275), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).